Lee s Pharmaceutical Hldgs Ltd Registered Shares HD -,05
- BID
0.121
- ASK
0.143
- 16,529 Units13,986 Units
- 07/22, 21:56:53 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
29.76%
Market Cap
-
P/E Ratio
9.74
Dividend Yield
2.96 %
Earnings per Share
0.02 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.121 G | 0 Units |
| PRICE DETERMINATION TIME | 07/22/2026 / 09:56:53 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.121 | 0.12 |
| PREV. DAY'S PRICE | 0.118 | (07/21) |
| CHANGE DAY BEFORE | +0.00 | 2.54 % |
| 52 WEEK HIGH / LOW | 0.272 (09/18) | 0.104 (05/28) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026 | 2027 | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.00 | 0.02 | 0.02 | - | - |
DIVIDENDS PER SHARE | 0.00 | 0.01 | 0.01 | - | - |
DIVIDEND YIELD IN % | 1.18 % | 3.17 % | 2.96 % | - | - |
DIVIDEND GROWTH IN % | -12.44 % | 150.69 % | -4.03 % | - | - |
PRICE - EARNINGS RATIO | 53.87 | 8.98 | 9.74 | - | - |
PRICE - BOOK RATIO | 0.44 | 0.51 | 0.44 | - | - |
PRICE - SALES RATIO | 0.86 | 0.60 | 0.62 | - | - |
PRICE - CASH FLOW RATIO | 7.92 | 3.46 | 2.67 | - | - |
Master Data
| WKN | A12CU5 |
| ISIN | KYG5438W1116 |
| SYMBOL | L1PA |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | LEE S PHARMACEUTIC.HD-,05 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 7.27 % | 7.27 % | -3.28 % | -26.71 % | -29.76 % | -25.79 % | -74.89 % | -28.48 % |
| HIGH | 0.12 | 0.12 | 0.13 | 0.20 | 0.27 | 0.27 | 0.48 | 0.20 |
| LOW | 0.11 | 0.11 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 | 0.10 |
Dividende
pro Aktie
Company profile
Lee's Pharmaceutical Holdings Ltd. engages in the development, manufacturing, and sale of pharmaceutical products. It operates through the Proprietary and Generic Products and Licensed-in Products segments. The Proprietary and Generic Products segment is involved in the manufacturing and sales of self-developed and generic pharmaceutical products. The Licensed-in Products segment focuses on the trading of licensed-in pharmaceutical products. The company was founded by Xiao Yi Li in 1994 and is headquartered in Hong Kong.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.